Albert Scardino
Chairman of the Board
Albert Scardino is a communications strategist who brings his broad international network to Immunovaccine’s Board. He is a Pulitzer prize winning journalist and has been an advisor to the chairman of the US Securities and Exchange Commission.
Dr. William A. Cochrane
Director
Dr. Cochrane is well recognized as the founding Dean of Medicine for the Faculty of Medicine at the University of Calgary and a strong businessman in the biotechnology industry.
Wade K. Dawe
Director
Wade K. Dawe has been an entrepreneur in Canadian mining and venture capital industries since 1994. He has significant experience in public markets and finance and has served on the Board of Immunovaccine Inc. since 2005.
James W. Hall
Director
Jim Hall has over 25 years of international finance experience and serves as Chair of Immunovaccine’s audit committee.
Wayne Pisano
Director
Mr. Pisano is the former chief executive of the world’s largest vaccine company, Sanofi Pasteur. His depth of experience and global connections are of significant benefit to Immunovaccine’s growth strategy.
Kimberly Stephens
Chief Financial Officer and Director
Ms. Kimberly Stephens is a Chartered Accountant with over ten years of financial management experience across several industries.
Brad Thompson
Director
Brad Thompson, Ph.D., is Executive Chairman, Chief Executive Officer and President of Oncolytics Biotech Inc. and is the current Chairman of BIOTECanada.
John Trizzino
Chief Executive Officer and Director
As a senior executive with more than 25 years of broad industry experience, Mr. Trizzino has been instrumental in creating joint ventures, licensing agreements and sales to major pharmaceutical companies and government agencies.
